Actio Biosciences, Inc.
Nicholas Stock is an accomplished leader in the field of medicinal chemistry with over two decades of experience in the biopharmaceutical industry. Currently serving as Executive Vice President and Head of Chemistry at Actio Biosciences, Inc., a position held since October 2022, Nicholas previously held senior roles at Genesis Therapeutics, including Senior Vice President and Vice President of Medicinal Chemistry. Additional experience includes roles at Inception Sciences, Inc., Amira Pharmaceuticals, and Merck, where Nicholas contributed to various aspects of drug development and chemistry. Nicholas earned a PhD in Organic Chemistry from Imperial College London and completed a post-doctoral fellowship at UC Irvine.
This person is not in any teams
This person is not in any offices
Actio Biosciences, Inc.
We’re leveraging advances in genetics and precision medicine to develop new therapeutics that target shared, underlying biology in rare and common diseases — bringing meaningful medicines from one to many. With expertise in genetics, drug discovery and data sciences, we seek to identify programs where both biological and technical risk can be minimized to streamline the drug development process and bring forward exceptionally potent and precisely targeted therapeutics for patients.